|1.||Kiss, Robert: 4 articles (06/2013 - 04/2010)|
|2.||Kopp, Brigitte: 3 articles (06/2013 - 04/2010)|
|3.||Moreno Y Banuls, Laetitia: 3 articles (06/2013 - 04/2010)|
|4.||Zehl, Martin: 3 articles (06/2013 - 04/2010)|
|5.||Urban, Ernst: 2 articles (06/2013 - 01/2013)|
|6.||Dufrasne, François: 1 article (06/2013)|
|7.||Gelbcke, Michel: 1 article (06/2013)|
|8.||Cimmino, Alessio: 1 article (01/2013)|
|9.||Berger, Walter: 1 article (01/2013)|
|10.||Karlish, Steven: 1 article (01/2013)|
04/23/2010 - "The in vitro growth inhibitory activity of these six compounds along with hellebrin (positive control) has been assayed by means of the MTT colorimetric assay in four human and two mouse cancer cell lines. "
06/28/2013 - "In addition, all genins and degradation products displayed weaker (if any) in vitro growth inhibitory effects on cancer cells when compared to their respective glycosylated homologue, with the exception of hellebrigenin (3b), which was as active as hellebrin (3a). "
11/01/2010 - "ouabain, 19-hydroxy-2″-oxovoruscharin, hellebrin and 19-hydroxy-hellebrin on PC-3 cancer cells incubated between 0 and 36 h in the absence (control) or the presence of the CS. "
01/01/2013 - "Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase."
01/01/2013 - "Altogether, these data show that the binding affinity of the bufadienolides and cardenolides under study is usually higher for the α2β1 and α3β1 than for the α1β1 NaK complex, excepted for hellebrin and its aglycone form, hellebrigenin, with hellebrigenin being as potent as hellebrin in inhibiting in vitro cancer cell growth."
|2.||Ouabain (G Strophanthin)
|7.||Adenosine Triphosphatases (ATPase)